Collaborative project seeks to close diagnostic gap in asthma care

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Regulatory Approval/Market Launch Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) 27.11.2024 /

November 28, 2024

Lilly says to ‘take some caution’ on other companies’ early-stage obesity data, calls out compounders

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 9, 2024

ADMA Biologics Inc Patent: Upper Respiratory Tract Infection Treatment

Share this article According to GlobalData’s company profile on ADMA Biologics, Anti-viral antigen-based compositions was a key innovation area identified from patents. ADMA Biologics‘s grant

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.